Quantcast

NovoPath Supports AP Lab Field with a Robust Conference Schedule Throughout 2013: Visit the Leading LIS Vendor at Outstanding Upcoming Events

August 20, 2013

NovoPath, an industry leader in anatomic pathology (AP) lab management and reporting IT solutions, continues its ongoing support of laboratory medical professionals and the lab software industry with a full schedule of conferences though the close of 2013.

Princeton, NJ (PRWEB) August 20, 2013

With a full schedule of conferences though the close of 2013, NovoPath, an industry leader in anatomic pathology (AP) lab management and reporting IT solutions, continues its ongoing support of laboratory medical professionals and the lab software industry. From its flagship NovoPath AP laboratory information system (LIS) to its sophisticated business tools, the company brings a range of its leading edge technology to these events and is an active participant in both formal and informal educational opportunities and in an exchange of ideas on the benefits of lab burgeoning technologies. Every year NovoPath takes part in a wide range of leading conferences covering a broad cross section of the industry on both a national and local level.

“NovoPath regards these conferences as an opportunity to support important professional organizations in the medical laboratory field and the lab community overall,” says Rick Callahan, VP of Sales and Marketing at NovoPath. “We devote significant resources to these conferences, in part, to participate in the many informative instructional and learning events as well as to actively interact as peers with all segments of the AP lab community. The opportunities to learn about new research and advocate for lab professionals are extremely important as are the opportunities to network, discuss and evaluate the benefits of the latest technological developments in the field.”

During Q3 and Q4 of 2013, NovoPath’s conference participation spans the AP lab field’s most important and prestigious events:

•American Society of Clinical Pathology – September 18 to 21 – Chicago, IL

The Society’s major annual conference brings together a global gathering of key opinion leaders in the clinical pathology field.

•Pathology Visions 2013 – Digital Pathology Association – September 29 to October 2 – San Antonio, TX

The Association’s annual conference provides opportunities to learn about practical, real-world applications in the evolving digital pathology field. Attendees preview the latest products, attend cutting-edge workshops with industry leaders, and earn CME credits.

•College of American Pathologists CAP ‘13 – October 12 to 16 – Kissimmee, FL

CAP ’13 provides an opportunity for board-certified pathologists, residents and subspecialty fellows to experience top-notch education and speakers, networking events, and opportunities to connect with industry leaders.

•American Society for Cytopathology – November 8 to 12 – Orlando, FL

The ASC’s annual meeting is devoted solely to cytopathology. The event draws industry, academia, and clinicians to discuss the latest trends and scientific breakthroughs in the field and network with their colleagues. The organization is made up of more than 3,000 pathologists, cytotechnologists, and clinical scientists dedicated to the diagnosis of cancer and related diseases through the cytologic method.

•Association of Molecular Pathology – November 14 to 16 – Phoenix, AZ

The AMP scientific meeting includes poster sessions and speakers for workshop and plenary sessions in each of the four major areas of clinical molecular diagnostics including: hematopathology, infectious disease, inherited genetic diseases, and solid tumors. The program also includes a keynote lecture by the distinguished recipient of the AMP Award for Excellence in Molecular Diagnostics.

•NJ Society of Pathology – November 16 – Holmdel, NJ

The 63rd Annual Meeting of the New Jersey Society of Pathologists is expected to draw 75 to100 participants from throughout the state.

•California Society of Pathologists – December 3 to 7 – San Francisco, CA

California Society of Pathologists’ (CSP) annual scientific program draws 250 pathologists, practice managers, professors and residents to engage in presentations and case studies. The 66th Annual Meeting will cover several new techniques and practical applications that pathologists can use today.

“NovoPath has always believed that supporting industry events is an important demonstration of our commitment to the field and to playing a role in industry leadership,” says Callahan. “The opportunities both to keep abreast of new developments in the field and to make a contribution to these events are outstanding.”

Since its inception, NovoPath has been recognized for its technologically-forward, flexible LIS solutions that can be customized to support a lab’s existing workflow and meet its evolving needs. NovoPath’s modular components enable sites to utilize the features that support their workflow without the need to purchase technology that does not meet the needs of their lab environment. NovoPath takes pride in offering leading edge products with value-based pricing and outstanding customer support. Today, NovoPath has one of the largest installation bases of among best-of-breed AP LIS solutions.    

About NovoPath, Inc.

NovoPath, Inc. develops and markets software solutions for the Anatomic Pathology Laboratory market segment that includes local, regional, national, and in-house laboratories as well as community and university teaching hospitals and medical centers. Since the release of its flagship product in 1999, NovoPath, Inc. has focused exclusively on Anatomic Pathology. NovoPath's mission is to provide unique and unparalleled solutions and services to all aspects of the Anatomic Pathology sector in a way that improves workflow, reduces the probability of human error, ensures results accuracy for greater patient safety, protects patient confidentiality, and above all, produces more precise and informative diagnostic outcomes. More information is available at http://www.NovoPath.com.

For the original version on PRWeb visit: http://www.prweb.com/releases/2013/8/prweb11039932.htm


Source: prweb



comments powered by Disqus